WHO ICTRP trial
Randomised Controlled Trial of the efficacy and safety of an Inhaled…
ACTRN12616000377437 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting
Key facts
| Trial ID | ACTRN12616000377437 |
|---|---|
| Public title | Randomised Controlled Trial of the efficacy and safety of an Inhaled Corticosteroid and Long Acting Beta Agonist reliever therapy regimen in asthma |
| Scientific title | A 52-week, open label, parallel group, multicentre, phase III, randomised controlled trial to compare the efficacy and safety of Budesonide/formoterol turbuhaler taken as required for relief of symptoms and Budesonide turbuhaler as maintenance and terbutaline turbuhaler as required for relief of… |
| Primary sponsor | Medical Research Institute of New Zealand |
| Registry | Australian New Zealand Clinical Trials Registry (ANZCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 3 |
| Countries | New Zealand;New Zealand;New Zealand;New Zealand |
| Conditions | Asthma; Asthma;Respiratory - Asthma |
| Interventions | Inhaled corticosteroid/Long acting beta Agonist (ICS/LABA) reliever therapy; budesonide/formoterol turbuhaler 200micrograms/6micrograms taken one inhalation for relief of symptoms as required for 52 weeks. These participants will receive no… |
| Registration date | Mar 23, 2016 |
| Target size | 890 |
| Secondary IDs | None known |
| Registry page | anzctr.org.au |
At a glance
- Yes Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: